Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/2005
06/08/2005EP1536850A1 Medical device having hydration inhibitor
06/08/2005EP1536840A2 Formulation for inwardly transferring nucleic acids into eucaryotic cells
06/08/2005EP1536834A2 Design of chemokine analogs for the treatment of human diseases
06/08/2005EP1536813A2 Compositions and methods comprising protein activated receptor antagonists
06/08/2005EP1536809A1 Use of fermented wheat germ extract as anti-inflammatory agent
06/08/2005EP1536801A2 Topical compositions and methods for treatment of adverse effects of ionizing radiation
06/08/2005EP1536797A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough
06/08/2005EP1536786A1 Combination of an allosteric inhibitor of matrix metalloproteinase-13 with celecoxib or valdecoxib
06/08/2005EP1536784A1 Hetero biaryl derivatives as matrix metalloproteinase inhibitors
06/08/2005EP1536778A2 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity
06/08/2005EP1465854A4 Chalcone derivatives and their use to treat diseases
06/08/2005EP1458706A4 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
06/08/2005EP1373269B1 Jun kinase inhibitors
06/08/2005EP1337526B1 Substituted imidazoles useful in the treatment of inflammatory diseases
06/08/2005EP1309575B1 Biphenyl derivatives and their use as ppar-gamma receptor activators
06/08/2005EP1252133B1 Pharmaceutical compounds
06/08/2005EP1220831B1 Biaryl ether derivatives useful as monoamine reuptake inhibitors
06/08/2005EP1176146B1 Carbamoyl tetrahydropyridine derivatives
06/08/2005EP1165031B1 Resorcinol composition
06/08/2005EP1042305B1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
06/08/2005EP0983304B1 Dermatan disulfate, an inhibitor of thrombin generation and complement activation
06/08/2005EP0849256B1 Amide compounds and use of the same
06/08/2005CN1625603A Genetic polymorphisms in the preprotachykinin gene
06/08/2005CN1625597A Novel elongase gene and method for producing polyunsaturated fatty acids
06/08/2005CN1625559A Novel compounds that inhibit factor Xa activity
06/08/2005CN1625412A Aldosterone antagonist and non-steroidal anti-inflammatory agent combination therapy to prevent or treat cardiovascular disorders
06/08/2005CN1625411A Combination of a NSAID and a PDE-4 inhibitor
06/08/2005CN1625400A 2, 4-pyrimidinediamine compounds and their uses
06/08/2005CN1625390A Multi-stage oral drug controlled-release system
06/08/2005CN1624115A Cell surface molecule mediating cell adhesion and signal transmission
06/08/2005CN1623599A Xiaoyao soft capsule and its preparation technology
06/08/2005CN1623572A Anti-inflammation medicine
06/08/2005CN1623567A Fast effect antiinflammation cold eliminating pain relieving liquid
06/08/2005CN1623547A Medical use of artificial lywrine
06/08/2005CN1205220C Novel cyclosporins
06/08/2005CN1205210C 9-azabicyclo (3,3,1) non-2-ene and nonane derivatives as cholinergic ligands at nicotinic ACH receptors
06/08/2005CN1205193C Crystalline form of 4-[5-methyl-3-phenylisoxazol)-4-yl] benzenesulfonamide
06/08/2005CN1205181C Matrix metalloproteinase inhibitors
06/08/2005CN1205176C Stable salts of o-acetylsalicyclic with basic amino acids
06/08/2005CN1204924C Liquid composition of biodegradable block copolymer for drug delivery system and process for preparation thereof
06/08/2005CN1204917C Complex rhizoma paridis tincture and preparing method thereof
06/08/2005CN1204884C N-acetyl-L cysteine for preparing medicine for treating epithelial tumous
06/08/2005CN1204883C Low dose diclofenac sodium lozenge and its preparation method
06/08/2005CN1204875C Delivery system for oral care compositions comprising organosiloxane resins using removable backing strip
06/08/2005CN1204870C Dental care compositions
06/07/2005US6903220 Synthesis of chiral 2-alkyl amino acids
06/07/2005US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/07/2005US6903187 Structural modification of clostridal neurotoxins including addition or deletion of a leucine-based motif to treat biological disorders include treating autonomic disorders, neuromuscular disorders and pain
06/07/2005US6903137 Agonists specific for the peripheral cannabinoid receptor
06/07/2005US6903135 Methods and products related to 16-HETE analogs
06/07/2005US6903134 Formulation comprising benzofuranone derivatives for protection against oxidative stress
06/07/2005US6903128 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
06/07/2005US6903115 Bipiperidine compounds
06/07/2005US6903098 Use of phthalazine derivatives
06/07/2005US6903096 Quinazoline derivatives as medicaments
06/07/2005US6903094 As analgesic
06/07/2005US6903089 Lactam-substituted pyrazolopyridine derivatives
06/07/2005US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4
06/07/2005US6903086 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists
06/07/2005US6903085 Substituted piperidine compounds useful as modulators of chemokine receptor activity
06/07/2005US6903082 Methods of treating inflammatory conditions of the gastrointestinal tract using 4-APAA and compositions thereof
06/07/2005US6902748 Medicines manufactured from old platycodon extracts
06/07/2005US6902746 Oral pharmaceutical compositions containing non-steroidal anti-inflammatory drugs and method for preparing the same
06/07/2005US6902739 Administering a stabilized rice bran derivative and a fortification agent; treating bone disorders
06/07/2005CA2348026C Antibodies against semp1, methods for their production and uses thereof
06/07/2005CA2299036C 4-phenyl-4-heteroarylpiperidine derivatives
06/07/2005CA2281090C Sulfonamide compounds and salts for treatment of endothelin-mediated disorders
06/07/2005CA2105529C Composition comprising non-steroidal anti-inflammatory agent and effectively non-antibacterial tetracycline
06/02/2005WO2005049631A1 Synthetic molecules having immune activity
06/02/2005WO2005049017A1 Anti-inflammatory, regenerating and antimicrobial composition
06/02/2005WO2003090514A3 Adipocyte complement related protein zacrp14
06/02/2005WO2003075847A3 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS
06/02/2005US20050119486 Diamine derivatives
06/02/2005US20050119333 Compositions comprising ether compounds and pharmaceutical uses therefor
06/02/2005US20050119320 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
06/02/2005US20050119316 Semicarbazide derivatives and the use thereof as antithrombotics
06/02/2005US20050119305 N-hydroxy-6-[(4-phenylbenzoyl)amino]hexanamide; hydroxamic acid derivative and equivalent thereof; antiinflammatory, anticarcinogenic, antiarthritic, antidiabetic agents; sepsis, leukemia, osteoporosis, skin disorders, cachexia, autoimmune diseases, hepatitis, endometriosis; hypergammaglobulinemia
06/02/2005US20050119304 N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(1H-indazol-5-yl)urea; vanilloid receptor (VR1) antagonist; blockage of neurotransmitter release
06/02/2005US20050119291 Pyrimidine compounds
06/02/2005US20050119290 N-(2-[N',N'-diethylamino]-5-[N''-(4-fluorophenylsulfonyl)-N''-propargylamino]pyrimidin-4-yl)-4'-(pyrrolidin-1-ylcarbonyloxy)-L-phenylalanine; antiinflammatory, antiarthritic agents
06/02/2005US20050119274 3-[5-chloro-6-methyl-2-(4-methyl-piperazin-1-yl)-pyrimidin-4-yl]-4-( 1H-indol-3-yl)-pyrrole-2,5-dione; T lymphocytes, Protein Kinase C (PKC) and glycogen synthase kinase 3 beta (GSK3B) mediated diseases;
06/02/2005US20050119267 Diazabicyclo alkane derivatives with nk1 antagonistic activity
06/02/2005US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase
06/02/2005US20050119216 Pharmaceutical compositions and methods relating to fucans
06/02/2005US20050119204 Osteopontin-related compositions and methods
06/02/2005US20050119164 Immunomodulatory polymeric antigens for treating inflammatory pathogies
06/02/2005US20050119162 Anxiolytic agents; using transferrins; quality of life for cancer patients; antiarthritic agents; antiinflammatory agents; compaction; uniform particle size
06/02/2005US20050118715 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
06/02/2005US20050118696 Methods and means for modulating PGE synthase activity
06/02/2005US20050118290 Compositions and method for treatment of steroid/nuclear receptor-mediated diseases
06/02/2005US20050118219 1,3,6-trihydroxy-7-methoxy-2,8-di (3-methyl-2-butenyl) xanthone; rosacea and/or telangiectasia, skin aging
06/02/2005US20050118168 Administering a compound which binds to a C-type lectin on the surface of a dendritic cell, with the proviso that the C-type lectin is not the DEC-205 receptor
06/02/2005CA2546028A1 Novel compounds
06/01/2005EP1536012A1 Human antihuman interleukin-6 antibody and fragment of the antibody
06/01/2005EP1536000A1 Method of judging inflammatory disease
06/01/2005EP1535922A1 Pyrrolopyridine derivative and use thereof
06/01/2005EP1535920A1 Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives
06/01/2005EP1535911A1 Metabolically inert anti-inflammatory and anti-tumor antifolates
06/01/2005EP1535910A1 Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of macrophage colony stimulating factor receptor
06/01/2005EP1535909A2 Cyclic amine derivatives and their use as drugs
1 ... 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 ... 1272